Skip to main content
SpringerLink
Log in
Book cover

Head and Neck Cancer pp 131–140Cite as

Cellular and molecular mechanisms of radioresistance

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 74))

Abstract

Outstanding work on the cellular and molecular aspects of radioresistance has been published in the past 10 years [1,2]. The work presented herein does not attempt to be comprehensive but is a review of the work of our laboratory as it pertains to aspects of radioresistance with potential applicability to chemotherapy/cytokine radiotherapy interactions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Peters LJ, Brock WA, Johnson T, Meyn RE, Tofilon PJ, Milas L. Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys 12:459–467, 1986.

    Article  PubMed  CAS  Google Scholar 

  2. Brock WA, Baker FL, Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 18:1283–1286, 1990.

    Article  PubMed  CAS  Google Scholar 

  3. Weichselbaum RR, Dahlberg W, Beckett MA, Karrison T, Miller D, Clark J, Ervin TJ. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head and neck cancer patients. Proc Natl Acad Sci USA 83:2684–2688, 1986.

    Article  PubMed  CAS  Google Scholar 

  4. Weichselbaum RR, Beckett MA, Vijayakumar S, Simon MA, Awan AA, Nachman J, Panje WR, Goldman ME, Tybor AG, Moran WJ, Vokes EE, Ahmed-Swan S, Farhangi, E. Radiobiological characterization of head and neck sarcoma cells derived from patients prior to radiotherapy. Int J Radiat Oncol Biol Phys 19:313–319, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Weichselbaum RR, Beckett MA, Schwartz JL, Dritschilo A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys 15:575–579, 1988.

    Article  PubMed  CAS  Google Scholar 

  6. Weichselbaum RR, Nove J, Little JB. Radiation response of human tumor cells in vitro. In: RH Withers, R Meyn, eds. Radiation Biology and Cancer Research. New York: Raven Press, 1980, pp 345–351.

    Google Scholar 

  7. Elkind MM, Sutton H. X-ray damage and recovery in mammalian cells in culture. Nature 184:1293–1295, 1969.

    Article  Google Scholar 

  8. Elkind MM. Fractionated dose radiotherapy and its relationship to survival curve shapes. Cancer Treat Rev 3:2–15, 1976.

    Article  Google Scholar 

  9. Nilsson S, Carlsson J, Larsson B. Survival of irradiated glia and glioma cells studied with a new cloning technique. Int J Radiat Biol 37:267–279, 1980.

    Article  CAS  Google Scholar 

  10. Weichselbaum RR, Dahlberg W, Little JB. Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci USA 87:4732–4735, 1985.

    Article  Google Scholar 

  11. Weichselbaum RR, Nove J, Little JB. X-ray sensitivity of 53 human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res 40:920–925, 1980.

    PubMed  CAS  Google Scholar 

  12. Withers HR. Biological basis of radiation therapy. In: CA Peres, LW Brady, eds. Principles and Practice of Radiation Oncology. Philadelphia: JB Lippincott, 1987, pp 67–98.

    Google Scholar 

  13. Phillips RA, Tolmach LJ. Repair of potentially lethal damage in x-irradiated HeLa cells. Radiat Res 29:413–432, 1966.

    Article  PubMed  CAS  Google Scholar 

  14. Weichselbaum RR, Nove J, Little JB. Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum. Nature 27:261–262, 1978.

    Article  Google Scholar 

  15. Weichselbaum RR, Schmit A, Little JB. Cellular repair factors influencing radiocurability of human malignant tumors. Br J Cancer 45:10–16, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Weichselbaum RR, Little JB. The differential response of human tumors to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer 46:532–537, 1982.

    Article  PubMed  CAS  Google Scholar 

  17. Weichselbaum RR, Beckett MA. The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. Int J Radiat Oncol Biol Phys 13:709–713, 1987.

    Article  PubMed  CAS  Google Scholar 

  18. Fu KK, Phillips TL. Biologic rationale of combined radiotherapy and chemotherapy. Hemotol/Oncol Clin North Am 5:737–751, 1991.

    CAS  Google Scholar 

  19. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911–934, 1990.

    PubMed  CAS  Google Scholar 

  20. Quiet C, Weichselbaum RR, Gradina D. Variation in radiation sensitivity during the cell cycle to two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 20:733–738, 1991.

    Article  PubMed  CAS  Google Scholar 

  21. Vokes EE, Panje WR, Schilsky RL, Mick R, Awan AM, Moran WJ, Goldman MD, Tybor AG, Weichselbaum RR. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761–768, 1989.

    PubMed  CAS  Google Scholar 

  22. Haraf DJ, Vokes EE, Panje WR, Weichselbaum RR. Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 14:419–426, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Weppelmann B, Wheeler RA, Peters GE, Kim RY, Spencer SA, Meredith RF, Salter MM. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea and reirradiation. Int J Radiat Oncol Biol Phys 22:1051–1056, 1992.

    Article  PubMed  CAS  Google Scholar 

  24. Guillot T, Wibault P, Cvitkovit E, Luboinski E, Tellez B, Eschwege F, Schwaab G, Armand JP. Treatment of ‘favorable’ recurrent (REC) head and neck squamous cell cancer (H+NSCC) with 5 days on/9 days simultaneous chemoradiotherapy (CH/RT) Vokes-Weichselbaum (VW) protocol (abstract #684). Proc Am Soc Clin Oncol 9:177, 1990.

    Google Scholar 

  25. Vokes EE, Beckett M, Karrison T, Weichselbaum RR. The interaction of 5-fluorouracil, hydroxyurea and radiation in two human head and neck cancer cell lines. Oncology 49:454–460, 1992.

    Article  PubMed  CAS  Google Scholar 

  26. Bohr VA, Evans MK, Fornace AJ. DNA repair and its pathogenetic implications. Lab Invest 61:143–161, 1989.

    PubMed  CAS  Google Scholar 

  27. Thompson LH, Brookman KW, Jones NJ, Allen SA, Carrano AV. Molecular cloning of the human XRCC-1 gene, which corrects defective DNA strand break repair and sister chromatid exchange. Mol Cell Biol 10:6160–6171, 1990.

    PubMed  CAS  Google Scholar 

  28. Dunphy EJ, Beckett MA, Thompson LH, Weichselbaum RR. Expression of the polymorphic human DNA repair gene XRCC-1 does not correlate with radiosensitivity in human head and neck tumor cell lines. Radiat Res 130:166–170, 1992.

    Article  PubMed  CAS  Google Scholar 

  29. Weinert TA, Hartwell LH. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317–322, 1988.

    Article  PubMed  CAS  Google Scholar 

  30. Mitchell JB, Cook JA, DeGraff W, Glatstein E, Russo A. Glutathione modulation in cancer treatment: Will it work? Int J Radiat Oncol Biol Phys 16:1289–1295, 1989.

    Article  PubMed  CAS  Google Scholar 

  31. Fitzgerald TJ, Daugherty C, Kase K, Rothstein LA, McKenna M, Greenberger JS. Activated human n-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less efficiently at low dose rates. Am J Clin Oncol 8:517–522, 1985.

    Article  PubMed  CAS  Google Scholar 

  32. Sklar MD. The ras-oncogenes increase the intrinsic resistance of NIH/3T3 cells to ionizing radiation. Science 239:645–657, 1989.

    Article  Google Scholar 

  33. Kasid U, Pfeifer A, Weichselbaum RR, Dritschilo A, Mark GE. The raf-oncogene is associated with the radiation-resistant human laryngeal cancer. Science 237:1039–1041, 1987.

    Article  PubMed  CAS  Google Scholar 

  34. Kasid U, Pfeifer A, Brennan T, Beckett MA, Weichselbaum RR, Dritschilo A, Mark GE. Effect of anti-sense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous cell carcinoma. Science 243:1354–1356, 1989.

    Article  PubMed  CAS  Google Scholar 

  35. Pirollo KF, Garner R, Yuan SY, Li L, Blather WA, Chang EH. Raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. Int J Radiat Biol 55:783–796, 1989.

    Article  PubMed  CAS  Google Scholar 

  36. Horiguchi J, Spriggs D, Imamura K, Stone R, Leubbers R, Kufe D. Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol ester. Mol Cell Biol 9:252–258, 1989.

    PubMed  CAS  Google Scholar 

  37. Rozengurt E, Rodriguez-Pena A, Coombs M, Sinnett-Smith J. Diacylglycerol stimulates DNA synthesis and cell division in mouse 3T3 cells: Role of Ca+ 2-sensitive phospholipid-dependent protein kinase. Proc Natl Acad Sci USA 81:5748–5752, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Hallahan D, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichselbaum RR. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 51:4565–4569, 1991.

    PubMed  CAS  Google Scholar 

  39. Hallahan DE, Sukhatme VP, Sherman ML, Virudachalam S, Kufe D, Weichselbaum RR. Protein kinase C mediates x-ray inducibility of nuclear signal transducers, egr-1 and c-jun. Proc Natl Acad Sci USA 88:2152–2160, 1991.

    Google Scholar 

  40. Hallahan DE, Virudachalam S, Schwartz JL, Panje N, Mustafi R, Weichselbaum RR. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res 129:345–350, 1992.

    Article  PubMed  CAS  Google Scholar 

  41. Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. Effects of radiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49:5066–5072, 1989.

    PubMed  CAS  Google Scholar 

  42. Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 51:2552–2558, 1991.

    PubMed  CAS  Google Scholar 

  43. Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, Weichselbaum RR. Increased tumor necrosis factor-alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86:10104–10107, 1989.

    Article  PubMed  CAS  Google Scholar 

  44. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87:1794–1797, 1991.

    Article  PubMed  CAS  Google Scholar 

  45. Hallahan DE, Beckett MA, Kufe D, Weichselbaum RR. Interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 19:69–74, 1990.

    Article  PubMed  CAS  Google Scholar 

  46. Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, Mac Vittie T. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 173:1177–1182, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ralph R. Weichselbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael A. Beckett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Everett E. Vokes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David G. Brachman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Haraf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dennis Hallahan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Donald Kufe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M. D. Anderson Cancer Center, The University of Texas, Houston, Texas, USA

    Waun Ki Hong M.D.  & Randal S. Weber M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Weichselbaum, R.R. et al. (1995). Cellular and molecular mechanisms of radioresistance. In: Hong, W.K., Weber, R.S. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2023-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2023-8_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5837-4

  • Online ISBN: 978-1-4615-2023-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation